Literature DB >> 27689809

Age related normogram for antral follicle count in general population and comparison with previous studies.

Gurkan Bozdag1, Pinar Calis2, Dila Zengin2, Atakan Tanacan2, Sevilay Karahan3.   

Abstract

OBJECTIVE: To construct antral follicle count (AFC) nomogram of general population for every age and to compare our data with previous studies to assess whether available AFC nomograms present any geographical inconsistency. STUDY
DESIGN: A prospective cross-sectional study was conducted to document AFC nomogram among women in 20-50 years with regular menstrual bleeding. Patients admitted with hirsutism, menstrual irregularity, diagnosis of current/history of endometrioma and hormonal drug use within the last 6 months were excluded. For the final analysis, a total of 381 eligible women were recruited in which all scanning was performed in the early follicular phase. The 25th, 50th and 75th percentiles were compared with previous nomogram.
RESULTS: The mean decrease of AFC in each year was 0.41. Among the age groups, there were no statistical significance between 20-24, 25-29 and 30-34, whereas decline in AFC was obvious after 35 years and beyond. The figures comparing our data and previous studies depicted similar steady decline at 25th, 50th and 75th percentiles.
CONCLUSION: The current age related nomogram presented a steady decline in AFC that became significant after 35 years in otherwise healthy women with regular menstrual bleeding. Those percentiles might be used as a reference guide to point out the current status of ovarian reserve for a given woman. Additionally, producing nomogram might enforce using percentiles instead of constant thresholds to define various medical conditions such as polycystic ovarian morphology or diminished ovarian reserve. However, longitudinal data with larger sample size are still needed for the validation of those percentiles.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antral follicle count; General population; Nomogram; Ultrasonography

Mesh:

Year:  2016        PMID: 27689809     DOI: 10.1016/j.ejogrb.2016.09.013

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.

Authors:  Lisa M Shandley; Amy Fothergill; Jessica B Spencer; Ann C Mertens; Hanh N Cottrell; Penelope P Howards
Journal:  Fertil Steril       Date:  2018-02-07       Impact factor: 7.329

2.  Salpingectomy may decrease antral follicle count but not live birth rate for IVF-ET patients aged 35-39 years: a retrospective study.

Authors:  Tong Chen; Feiyan Zhao; Qin Wang; Chang Liu; Yonglian Lan; Shuyu Wang; Zhimin Xin; Xiaokui Yang
Journal:  J Ovarian Res       Date:  2020-07-20       Impact factor: 4.234

3.  Gynecologic assessment of 19 adult females with cartilage-hair hypoplasia - high rate of HPV positivity.

Authors:  Elina Holopainen; Svetlana Vakkilainen; Outi Mäkitie
Journal:  Orphanet J Rare Dis       Date:  2018-11-16       Impact factor: 4.123

4.  Endocrine Disorders and Genital Infections Impair Gynecological Health in APECED (APS-1).

Authors:  Viivi Saari; Saila Laakso; Aila Tiitinen; Outi Mäkitie; Elina Holopainen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-30       Impact factor: 5.555

Review 5.  Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.

Authors:  Loes M E Moolhuijsen; Jenny A Visser
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

6.  Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients.

Authors:  Sandro C Esteves; Hakan Yarali; Lan N Vuong; José F Carvalho; İrem Y Özbek; Mehtap Polat; Ho L Le; Toan D Pham; Tuong M Ho
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.